Blue Crest Capital Management LTD Rigel Pharmaceuticals Inc Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $161,395 - $260,715	-77,594 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $201,744 - $278,562	77,594 New	77,594 $249,000
Q4 2017 Feb 14, 2018	SELL	$3.23 - $4.3 $34,073 - $45,360	-10,549 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $22,996 - $27,110	10,549	10,549 $27,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.